Global Agentic AI In Healthcare Market Size is valued at USD 713.37 Million in 2025 and is predicted to reach USD 31,340.28 Billion by the year 2035 at an 46.1% CAGR during the forecast period for 2026 to 2035.
Agentic AI In Healthcare Market Size, Share & Trends Analysis Distribution by Agent System (Single Agent Systems, Multi Agent Systems), Product (Ready-to-Deploy Agents, Build-Your-Own Agents), Technology (Machine Learning, Natural Language Processing, Context-aware Computing, Computer Vision), Application (Medical Imaging, Risk Prediction & Pandemic Preparedness, Genomic Data Analysis, Chronic Disease Management, Personalized Treatment & Drug Discovery, Electronic Health Records (EHRs), Medical Research & Data analysis, Remote Patient Care, Clinical Decision-Making, Hospital Resource Optimization), End-use (Healthcare Providers, Healthcare Companies, Academic & Research Institutes, Healthcare Payers) and Segment Forecasts, 2026 to 2035.

Agentic AI, in the context of healthcare, is self-governing AI systems that can make decisions and execute tasks independently. Such systems are programmed to evaluate intricate medical information, forecast outcomes, and offer recommendations or actions in real-time. Agentic AI, unlike traditional AI, can perform actions like resource management, treatment plan optimization, and precision diagnostics alongside offering insights. Personalized medicine, drug development, diagnostics, and remote patient monitoring are some of its uses.
Agentic AI aims to enhance patient outcomes as well as healthcare staff shortages through the use of machine learning and advanced algorithms to enhance accessibility, accuracy, and efficiency. Among the prime drivers of the agentic AI in healthcare industry are the increased need for customized healthcare solutions, the rapid pace of development in AI technology, the trend towards preventative care within the healthcare sector, and the incorporation of AI in diagnosis. Other drivers of market growth are the rising automation of repetitive tasks, the rising focus on resource and cost efficiency, and the increasing adoption of enhanced patient care solutions. AI agents also accelerate the research and development processes of the pharmaceutical industry.
Some of the Key Players in Agentic AI In Healthcare Market:
The Agentic AI In Healthcare market is segmented based on Agent System, product, technology, application, and end-use. Based on Agent System, the market is segmented into Single Agent Systems and Multi Agent Systems. By product, the market is segmented into Ready-to-Deploy Agents and Build-Your-Own Agents. By technology, the market is segmented into Machine Learning (Deep Learning, Supervised, Unsupervised, Others (Reinforcement Learning, Semi-supervised)), Natural Language Processing (Smart Assistance, OCR (Optical Character Recognition), Auto Coding, Text Analytics, Speech Analytics, Classification & Categorization), Context-aware Computing, and Computer Vision.
By application, the market is segmented into Medical Imaging, Risk Prediction & Pandemic Preparedness, Genomic Data Analysis, Chronic Disease Management, Personalized Treatment & Drug Discovery, Electronic Health Records (EHRs), Medical Research & Data analysis, Remote Patient Care, Clinical Decision-Making, Hospital Resource Optimization, and Others. Based on end-use, the market is segmented into Healthcare Providers, Healthcare Companies, Academic & Research Institutes, Healthcare Payers, and Others.
The Ready-to-Deploy Agents segment is poised to capture a significant global market share due to their ability to be rapidly installed, save costs, possess better scalability, and make decisions. Ready-to-deploy AI agents equipped with advanced algorithms and machine learning capability enhance decision-making processes in healthcare environments. They rapidly and accurately assess vast amounts of information, providing insights that guide doctors in making informed decisions regarding patient care, resource utilization, and treatment regimens. Additionally, these agents enable interoperability for more smooth data exchange among different platforms, such as billing systems and electronic health records (EHRs), which reduces data silos and enhances overall workflow efficiency.
The medical imaging segment had the highest market share. The ability of AI agents to enhance image processing, enhance the accuracy of diagnosis, and reduce interpretation times is accountable for this growth, which sustains the radiologists' workflows. Medical image interpretation, such as MRIs, CT scans, X-rays, and mammograms, is quickly being automated using AI agents. AI is able to detect patterns and abnormalities that might be hard for human radiologists to detect. The device has shown some promise in accurately diagnosing diseases, including cancer and fractures. Through this capability, it is expected to increase diagnostic confidence by providing a second opinion and assisting radiologists better in their diagnosis.
The North American Agentic AI In Healthcare industry is likely to hold the maximum market share in terms of revenue in the foreseeable future. Extensive use of AI/ML technologies, encouraging government policies, profitable funding possibilities, developments in healthcare IT infrastructure, increasing healthcare costs, and the availability of a number of major businesses are some of the reasons for this. Ageing populace, shifting lifestyle, growing incidence of chronic diseases, need for value-based care, and improving awareness about the use of AI-based technologies are a few factors propelling the market growth in North America. Asia Pacific is also expected to expand at a very high rate in the international Agentic AI In Healthcare market.
The adoption rates in the region are being fueled by an increase in investments from venture capitalists, private investors, and non-profits that aim to enhance healthcare outcomes, enhance data security and analytics, and reduce expenditure. Further, the market is expected to grow with the help of favorable government initiatives that drive healthcare providers and organizations to adopt AI-based technology. Additionally, the market is expanding as a result of higher healthcare spending and technological advancements in healthcare IT.

| Report Attribute | Specifications |
| Market Size Value In 2025 | USD 713.37 Million |
| Revenue Forecast In 2035 | USD 31,340.28 Billion |
| Growth Rate CAGR | CAGR of 46.1% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Mn and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Agent System, Product, Technology, Application, End-Use, and By Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | nVIDIA, Oracle, Microsoft, Thoughtful Automation Inc., Hippocratic AI Inc., Cognigy, Amelia US LLC, Beam AI., Momentum, Notable, Springs |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Agentic AI In Healthcare Market-
Agentic AI In Healthcare Market By Agent System-

Agentic AI In Healthcare Market By Product-
Agentic AI In Healthcare Market By Technology-
Agentic AI In Healthcare Market By Application-
Agentic AI In Healthcare Market By End-use-
Agentic AI In Healthcare Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.